{
  "main_header": {
    "sid": 1000019,
    "name": "Alkem Lab",
    "stock_name": "Alkem Lab",
    "full_name": "Alkem Laboratories Ltd",
    "name_url": "stocks-analysis/alkem-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "5,720.05",
    "chg": 205.1,
    "chgp": "3.72%",
    "dir": 1,
    "prev_price": "5,514.95",
    "mcapval": "67,650.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 539523,
    "symbol": "ALKEM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE540L01014",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "1.77 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/alkem-lab-1000019-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "1000019",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/alkem-laboratories-1000019"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Board Meeting Intimation For Notice Of Meeting Of Board Of Directors Of Alkem Laboratories Limited.",
      "datetime": "23-Jan-2026",
      "details": "Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve (i) the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended 31st December 2025; and (ii) Interim Dividend for financial year 2025-2026. The record date for the purpose of payment of Interim Dividend for financial year 2025-2026 would be Friday 20th February 2026 subject to declaration of the said Interim Dividend by the Board of Directors in its meeting to be held on 13th February 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "23-Jan-2026",
      "details": "With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we write to inform you that a conference call to discuss the Q3 and 9MFY26 financial results will be held on Friday February 13 2026 at 04.00 p.m. Please find attached herewith the conference call details.",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of SEBI LODR",
      "datetime": "22-Jan-2026",
      "details": "Please find attached herewith disclosure in respect of order passed by the Statutory Authority.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alkem Laboratories Ltd has declared <strong>400%</strong> dividend, ex-date: 08 Aug 25",
          "dt": "2025-08-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News